[{"id":"91f3a5f3-0bcd-4dcd-9557-8c9b79ef00a9","acronym":"IMMUNONET","url":"https://clinicaltrials.gov/study/NCT05605496","created_at":"2024-03-07T15:34:01.869Z","updated_at":"2025-02-25T14:41:39.354Z","phase":"Phase 2","brief_title":"NP137 Clinical and Biological Activities Assessment in Patients with Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies","source_id_and_acronym":"NCT05605496 - IMMUNONET","lead_sponsor":"Centre Leon Berard","biomarkers":" NTN1","pipe":"","alterations":" ","tags":["NTN1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NP137"],"overall_status":"Recruiting","enrollment":" Enrollment 87","initiation":"Initiation: 01/06/2023","start_date":" 01/06/2023","primary_txt":" Primary completion: 02/24/2026","primary_completion_date":" 02/24/2026","study_txt":" Completion: 11/24/2026","study_completion_date":" 11/24/2026","last_update_posted":"2025-02-14"},{"id":"d2f054cb-d7d7-428e-a668-4ef427551575","acronym":"HCC-Net","url":"https://clinicaltrials.gov/study/NCT04766736","created_at":"2021-05-16T09:07:36.518Z","updated_at":"2024-07-02T16:36:34.243Z","phase":"","brief_title":"Netrin-1 \u0026 Hepatocellular Carcinoma HCC","source_id_and_acronym":"NCT04766736 - HCC-Net","lead_sponsor":"Hospices Civils de Lyon","biomarkers":" NTN1","pipe":"","alterations":" ","tags":["NTN1"],"overall_status":"Recruiting","enrollment":" Enrollment 320","initiation":"Initiation: 07/01/2019","start_date":" 07/01/2019","primary_txt":" Primary completion: 06/30/2021","primary_completion_date":" 06/30/2021","study_txt":" Completion: 12/31/2022","study_completion_date":" 12/31/2022","last_update_posted":"2021-02-23"}]